Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are two of the most valuable healthcare stocks in the world, largely due ...
Losing weight by dieting (restricting energy) includes, along with fat loss, losing lean mass, about half of which is ...
Obese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic ...
Injectable GLP-1 agonists help people struggling to lose weight. Patients are finding the drug also helps reduce recurring ...
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...
As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, ...
KEEN to lose weight in 2025? So are almost half of our readers. While weight-loss jabs, similar to Ozempic, boomed in ...
GLP-1 weight-loss drugs are cutting calories… and grocery bills, according to a new study from Cornell and Numerator.
In January 2023, the world was abuzz with stories of a revolutionary weight-loss drug – a simple, self-administered injection ...
New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight ...
With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback